ABOUT SIRPIGLENASTAT

“This particular prodrug design made DON qualified to its supposed place (tumor) and also have a lot less of an influence on balanced cells somewhere else.”It has anticancer consequences by instantly focusing on tumor metabolism and simultaneously inducing a strong antitumor immune response with immunomodulatory and antineoplastic activities.DR